American Society of Clinical Oncology

SHERPA: White

People

  1. Scher
    Scher
  2. Schoder
    Schoder
  3. Slovin
    Slovin
  4. Autio
    Autio
  5. Fox
    Fox
  6. Humm
    Humm
  7. Lewis
    Lewis
  8. Morris
    Morris
  9. Wang
    Wang
  10. Zanzonico
    Zanzonico

Groups

  1. Department of Medicine (4)
  2. GSK Faculty (4)
  3. Genitourinary Oncology Service (4)
  4. Hematologic Malignancies, Division of (4)
  5. Medical Physics (4)
  6. Molecular Imaging and Therapy Service (4)
  7. Radiology, Department of (4)
  8. Solid Tumor Oncology Division (4)
  9. Molecular Pharmacology and Chemistry Program Faculty (3)
  10. Sloan Kettering Institute Faculty (3)
Search Within
  1. "Susan Slovin"
  2. "Heiko Schoder"
Formats
  1. Meeting Abstract (4)
Groups
  1. Department of Medicine (4)
  2. GSK Faculty (4)
  3. Genitourinary Oncology Service (4)
  4. Hematologic Malignancies, Division of (4)
  5. Medical Physics (4)
  6. Molecular Imaging and Therapy Service (4)

More Groups

People
  1. Heiko Schoder (4)
  2. Howard Scher (4)
  3. Susan Slovin (4)
  4. Gabrielle Arauz (2)
  5. Isabelle Riviere (2)
  6. Jason Lewis (2)

More People

Years
  1. 2014 (1)
  2. 2013 (3)
Publications
  1. Journal of Clinical Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save